JVS Author Spotlight- Bath, Lawrence and Mendes

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by MD/PhD student Rahul Ghosh (@ghoshrx), JVS editor-in-chief Dr. Thomas Forbes (@TL_Forbes), JVS Assistant Editor Dr. Paul Dimuzio (@pdimuziomd), and Associate Editor of the Journal of Vascular Surgery-Cases, Innovations and Techniques, Dr. Sherene Shalhub (@ShereneShalhub, @OHSUvascular), to discuss two great articles in the JVS family of journals regarding uncommon vascular conditions, including aberrant subclavian artery/Kommerell's diverticulum and vascular Ehlers-Danlos syndrome. This episode hosts Dr. Jonathan Bath, Dr. Peter Lawrence, and Dr. Bernardo Mendes, the authors of the following papers:   Articles: Contemporary Outcomes after Treatment of Aberrant Subclavian Artery and Kommerell's Diverticulum by Bath et al. Open repair of an infected abdominal aortic aneurysm in a patient with vascular Ehlers-Danlos syndrome by Mendes et al. Show Guests: Dr. Jonathan Bath (@MizzouVascular) -  Assistant Professor of Surgery and program director for vascular fellowship at the University of Missouri Dr. Peter Lawrence - Professor of surgery at @UCLAVascular, served as senior editor for both JVS and JVS-VL previously.  Dr. Benardo Mendes (@drbermendes) - Consultant in the Division of Vascular and Endovascular Surgery at Mayo Clinic, and is Associate Professor of Surgery at Mayo Clinic College of Medicine and Science.  Additional Notes: Vascular Low Frequency Disease Consortium Website  Visit here for a list of completed projects and publications. The VEDS Collaborative research study is still enrolling! Any patient interested in enrolling should reach out to [email protected] and follow @VEDSCollabo and @OHSUvascular on Twitter. JVS-CIT will be dedicating a full virtual issue to patients with genetic aortopathy and arteriopathy. Resources for patients: https://thevedsmovement.org/ and https://www.ehlers-danlos.com/  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

There are no comments yet.

Please log in to write the first comment.